The following represents disclosure information provided by authors of this abstract. The program committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered compensated. Relationships are self-held unless otherwise noted. I = Immediate Family Member, Inst = My Institution
 
Open Payments is a public database containing information reported by companies about payments made to US-licensed physicians (Open Payments)
Nectin-4 targeted ADC, SHR-A2102, in patients with advanced or metastatic urothelial carcinoma: A phase 1 study.
 
Bixia Tang
No Relationships to Disclose
 
Xinan Sheng
Speakers' Bureau - Astellas Pharma; Junshi Pharmaceuticals; MSD Oncology; Pfizer; RemeGen
 
Jun Guo
Consulting or Advisory Role - Bayer; MSD; Novartis; Oriengene; Pfizer; Roche; Shanghai Junshi BioSciences; Simcere
 
Haitao Niu
No Relationships to Disclose
 
Yali Shen
No Relationships to Disclose
 
Shusuan Jiang
No Relationships to Disclose
 
Bin Fu
No Relationships to Disclose
 
Jianming Guo
No Relationships to Disclose
 
Wasilijiang Wahafu
No Relationships to Disclose
 
Kai Yao
No Relationships to Disclose
 
Nan Liu
No Relationships to Disclose
 
Jiang Gu
No Relationships to Disclose
 
Yu Chen
No Relationships to Disclose
 
Zhenhua Li
No Relationships to Disclose
 
Tianxin Lin
No Relationships to Disclose
 
Liping Ma
No Relationships to Disclose
 
Jiaqin Lin
Employment - Jiangsu Hengrui Pharmaceuticals
 
Chi Zhang
Employment - Jiangsu Hengrui Pharmaceuticals
 
Wenliang Wang
Employment - Jiangsu Hengrui Pharmaceuticals